Skip to main content

Nasdaq Technology

Dr. Reddy's Settles Revlimid Patent Suit With Bristol Myers

6 years 1 month ago
Shares of Dr. Reddy’s Laboratories Ltd. RDY grew 6.3%, after it announced a settlement of its litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb BMY, relating to patents for Revlimid (lenalidomide) capsules. Revlimid is a prescription medicine,used to t
Zacks
Checked
17 minutes 4 seconds ago
This feed is responsible for generating the rss feed related to the topic Technology
Subscribe to Nasdaq Technology feed